BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Aerie Pharmaceuticals Announces Appointment of Tad Heitmann as Head of Communications

  Aerie today announced the appointment of Tad Heitmann as Head of Communications, reporting to Judith Robertson, Aerie’s Chief Commercial Officer.

  February 1, 2018

   · 

  5 min read
• BioForest

  Seattle Genetics Announces Pricing of Public Offering of Common Stock

  Seattle Genetics, Inc. today announced the pricing of an underwritten public offering of 11,538,461 shares of its common stock at a price to the public of $52.00 per share.

  February 1, 2018

   · 

  3 min read
• Business

  Domainex Appoints Dr Kevin Doyle as Head of Chemistry

  Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce that Dr Kevin Doyle has been appointed Head of Chemistry with immediate effect.

  February 1, 2018

   · 

  1 min read
• BioMidwest

  Fagron Extends Pharmaceutical Ingredient Supply Chain to American Pharmaceutical Ingredients’ Customers

  Fagron was recently selected by American Pharmaceutical Ingredients to directly service API’s customers with continued supply of active ingredients for compounding.

  February 1, 2018

   · 

  2 min read
• Biotech Beach

  BD Launches New Los Angeles County Program to Equip Patients with Essential Resources for Safe Sharps Disposal

  The launch of the new BD” CARD Your Sharps” initiative provides patients with a new sharps containment device, at no cost, and directs them to the nearest sharps take-back location.

  February 1, 2018

   · 

  5 min read
• Business

  ReShape Lifesciences Reports Preliminary Fourth Quarter and Full Year 2017 Revenue

  ReShape Lifesciences announced today preliminary revenue results for the fourth quarter and year ended December 31, 2017.

  February 1, 2018

   · 

  4 min read
• Business

  West to Host Fourth-Quarter and Full-Year 2017 Conference Call

  A live broadcast of the conference call will be available at the Company’s website, www.westpharma.com, in the “Investors” section.

  February 1, 2018

   · 

  2 min read
• Business

  Flagship Pioneering Catalyzes Growth With New Leadership Appointments

  Flagship Pioneering today announcing the appointment of two new partners: Rob Rosiello, executive partner and chief operating officer, and Jason Pontin, senior partner and chief editor.

  February 1, 2018

   · 

  5 min read
• Business

  Syndax Announces Immuno-Oncology Clinical Trial Collaboration With AstraZeneca

  Under the terms of the agreement, Syndax and Astra will collaborate on a non-exclusive basis to evaluate the combination of the two drugs in multiple solid tumor types.

  February 1, 2018

   · 

  4 min read
• FDA

  Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

  The IND supports the company’s ongoing Phase 1/2 clinical trial of IMG-7289 for myelofibrosis.

  February 1, 2018

   · 

  2 min read